Literature DB >> 19236621

Decreased circulating CD34+ cells are associated with progression of diabetic nephropathy.

H Makino1, S Okada, A Nagumo, T Sugisawa, Y Miyamoto, I Kishimoto, A Kikuchi-Taura, T Soma, A Taguchi, Y Yoshimasa.   

Abstract

AIMS: Circulating progenitor cells such as CD34+ cells play a key role in maintenance of vascular endothelial function and neovascularization, and a decrease in the number of CD34+ cells is associated with cardiovascular disease. However, the contribution of circulating progenitor cells to microvascular disease, such as diabetic nephropathy, is unclear. This study was therefore designed to clarify the association between diabetic nephropathy and circulating CD34+ cells.
METHODS: We measured circulating CD34+ cell numbers in 85 Type 2 diabetic patients aged 40-70 years with normo- and microalbuminuria and determined the association with urinary albumin excretion rate (UAER).
RESULTS: The number of circulating CD34+ cells significantly correlated with log UAER (r = -0.289, P = 0.008). Furthermore, in patients with low numbers of CD34+ cells (0.68 > cells/microl, lowest quartile of CD34+ cell number) UAER increased significantly after 12 months compared with baseline [from 34.3 +/- 7.0 to 53.6 +/- 10.8 mg/g creatinine (gCr), P < 0.05], whereas in patients with a high number of CD34+ cells (1.0 < cells/microl, highest quartile of CD34+ cell number) UAER did not change (from 16.7 +/- 4.8 to 20.1 +/- 3.0 mg/gCr).
CONCLUSIONS: These results suggest that a decreased number of circulating CD34+ cells is involved in the progression of diabetic nephropathy and may be a predictor of the disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19236621     DOI: 10.1111/j.1464-5491.2008.02638.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  17 in total

1.  Growth factors/chemokines in diabetic vitreous and aqueous alter the function of bone marrow-derived progenitor (CD34⁺) cells in humans.

Authors:  Sankarathi Balaiya; Maria B Grant; Joshua Priluck; Kakarla V Chalam
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-26       Impact factor: 4.310

Review 2.  A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications.

Authors:  G P Fadini
Journal:  Diabetologia       Date:  2013-10-31       Impact factor: 10.122

3.  Microalbuminuria is associated with impaired arterial and venous endothelium-dependent vasodilation in patients with Type 2 diabetes.

Authors:  A M V Silva; B D Schaan; L U Signori; R D M Plentz; H Moreno; M C Bertoluci; M C Irigoyen
Journal:  J Endocrinol Invest       Date:  2010-03-30       Impact factor: 4.256

Review 4.  Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.

Authors:  Gian Paolo Fadini; Douglas Losordo; Stefanie Dimmeler
Journal:  Circ Res       Date:  2012-02-17       Impact factor: 17.367

Review 5.  Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent.

Authors:  Johannes C Grisar; Francois Haddad; Fatemeh A Gomari; Joseph C Wu
Journal:  Biomark Med       Date:  2011-12       Impact factor: 2.851

6.  The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.

Authors:  Gian Paolo Fadini; Elisa Boscaro; Mattia Albiero; Lisa Menegazzo; Vera Frison; Saula de Kreutzenberg; Carlo Agostini; Antonio Tiengo; Angelo Avogaro
Journal:  Diabetes Care       Date:  2010-03-31       Impact factor: 19.112

Review 7.  Aesthetic cardiology: adipose-derived stem cells for myocardial repair.

Authors:  Nathan J Palpant; Joseph M Metzger
Journal:  Curr Stem Cell Res Ther       Date:  2010-06       Impact factor: 3.828

Review 8.  Renal vascular structure and rarefaction.

Authors:  Alejandro R Chade
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

Review 9.  The endothelium in diabetic nephropathy.

Authors:  Richard E Gilbert
Journal:  Curr Atheroscler Rep       Date:  2014-05       Impact factor: 5.113

10.  Circulating vascular progenitor cells in patients with type 1 diabetes and microalbuminuria.

Authors:  Cecile Dessapt; Janaka Karalliedde; Maria Hernandez-Fuentes; Paz Prieto Martin; Giuseppe Maltese; Nikesh Dattani; Ravinder Atkar; Giancarlo Viberti; Luigi Gnudi
Journal:  Diabetes Care       Date:  2010-01-12       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.